Search Results - "Shenton, B.K."

Refine Results
  1. 1
  2. 2
  3. 3

    Ischemia-reperfusion injury in cadaveric nonheart beating, cadaveric heart beating and live donor renal transplants by Gok, M A, Shenton, B K, Pelsers, M, Whitwood, A, Mantle, D, Cornell, C, Peaston, R, Rix, D, Jaques, B C, Soomro, N A, Manas, D M, Talbot, D

    Published in The Journal of urology (01-02-2006)
    “…Ischemia-reperfusion injury is gaining importance in transplantation as being responsible for allograft dysfunction. Ischemia occurs during kidney procurement,…”
    Get more information
    Journal Article
  4. 4

    Use of real-time PCR to measure Epstein–Barr virus genomes in whole blood by Leung, E, Shenton, B.K, Jackson, G, Gould, F.K, Yap, C, Talbot, D

    Published in Journal of immunological methods (15-12-2002)
    “…The measurement of the Epstein–Barr viral load in peripheral blood has been recognised as an important way of monitoring the response to treatment in patients…”
    Get full text
    Journal Article
  5. 5

    Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler by Leung, E., Shenton, B.K., Green, K., Jackson, G., Gould, F.K., Yap, C., Talbot, D.

    Published in Transplant infectious disease (01-12-2004)
    “…: Background: Epstein–Barr virus (EBV) is recognised as one of the causative agents for most cases of post‐transplant lymphoproliferative disease (PTLD)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    MUC1 expression in primary breast cancer: the effect of tamoxifen treatment by HANSON, J. M, BROWELL, D. A, PEARSON, J. P, CUNLIFFE, W. J, VARMA, J, ALLEN, A, HEMMING, D, SHENTON, B. K, YOUNG, J. R, HIGGS, M. J, BROTHERICK, I

    Published in Breast cancer research and treatment (01-06-2001)
    “…This was a non-randomised single institution retrospective study. Forty-six banked frozen tumour specimens were obtained from a group of patients who had…”
    Get full text
    Journal Article
  8. 8

    The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population by Heer, R., Robson, C.N., Shenton, B.K., Leung, H.Y.

    Published in Journal of cellular physiology (01-09-2007)
    “…Abnormal differentiation in epithelial stem cells or their immediate proliferative progeny, the transiently amplifying population (TAP), may explain malignant…”
    Get full text
    Journal Article
  9. 9

    Vimentin Antibodies: A Non-HLA Antibody as a Potential Risk Factor in Renal Transplantation by Carter, V., Shenton, B.K., Jaques, B., Turner, D., Talbot, D., Gupta, A., Chapman, C.E., Matthews, C.J., Cavanagh, G.

    Published in Transplantation proceedings (01-03-2005)
    “…Chronic allograft rejection is the major problem encountered in solid organ transplantation and is the end point of several complex processes. A number of…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population by Heer, R., Robson, C.N., Shenton, B.K., Leung, H.Y.

    Published in Journal of cellular physiology (01-04-2008)
    “…The original article to which this erratum refers was published in J Cell Phys (2007) 212:572–578. J. Cell. Physiol. 215: 283–284, 2008. © 2007 Wiley‐Liss, Inc…”
    Get full text
    Journal Article
  11. 11

    The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines by Aspinall, S.R., Stamp, S., Davison, A., Shenton, B.K., Lennard, T.W.J.

    “…Epidemiological studies suggest that precursor steroids are implicated in the aetiology of breast cancer. However, our understanding of the role of precursor…”
    Get full text
    Journal Article
  12. 12

    Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation by Talbot, D, Shenton, B K, Buckley, P E, Gok, M A

    Published in The Journal of urology (01-10-2003)
    “…With the continuing shortage of suitable donors increasing interest is being shown in nonheart beating donation. Such a resource is a new and, therefore, an…”
    Get more information
    Journal Article
  13. 13

    Anti-vimentin Antibody Detection in Recipients of Heart-Beating and Non–Heart Beating Donor Kidneys by Mi, H., Carter, V., Gupta, A., Asher, J., Shenton, B.K., Stamp, S., Wong, Y.T., Gok, M.A., Talbot, D.

    Published in Transplantation proceedings (01-10-2005)
    “…Alternative donor sources include non–heart-beating donors (NHBDs). There donors have been exposed to significant ischemia, so that it is common to utilize…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Breast 01 by Aspinall, S.R., Stamp, S.J., Brotherick, I., Shenton, B.K., Griffiths, A.B., Griffiths, C.D.M., Lennard, T.W.J.

    Published in British journal of surgery (2002)
    “…Background: The role of oestrogen and progesterone receptors in breast cancer has been extensively investigated; however, the androgen receptor has received…”
    Get full text
    Journal Article
  15. 15

    Breast 12 by Aspinall, S.R., Stamp, S.J., Brotherick, I., Cook, D.B., Shenton, B.K., Griffiths, A.B., Griffith, C.D.M., Bliss, R., Lennard, T.W.J.

    Published in British journal of surgery (2002)
    “…Background: The preliminary results of the IMPACT trial have shown that aromatase inhibitors are the preferred first‐line hormonal treatment for advanced…”
    Get full text
    Journal Article
  16. 16

    Cardiovascular Risk Assessment Scoring System for the Determination of Cardiovascular Mortality in Renal Transplant Patients by Gupta, A., Wroe, C., Mi, H., Asher, J., Gok, M.A., Shenton, B.K., Ward, M., Talbot, D.

    Published in Transplantation proceedings (01-10-2005)
    “…It is well known that the greatest risk for mortality post–renal transplant is cardiovascular death. We compared a modified cardiac risk assessment system…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Do Recipients of Kidneys From Donors Treated With Streptokinase Develop Anti-streptokinase Antibodies? by Mi, H., Gupta, A., Gok, M.A., Asher, J., Shenton, B.K., Stamp, S., Carter, V., Martin, J. Del Rio, Soomro, N.A., Jaques, B.C., Manas, D.M., Talbot, D.

    Published in Transplantation proceedings (01-10-2005)
    “…Streptokinase is used for preflush for non–heart-beating donors (NHBDs) in our center. The aim of this study was to evaluate whether the use of thrombolytic…”
    Get full text
    Journal Article Conference Proceeding
  18. 18
  19. 19
  20. 20